Index
-
Market Cap
243.19M
Enterprise Value
-191.09M
Income
-69.20M
Sales
84.43M
Book/sh
1.41
Cash/sh
1.17
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
389
IPO
Feb 10, 2011
P/E
-
Forward P/E
-
PEG
-
P/S
2.88
P/B
0.44
P/C
0.53
P/FCF
-
EV/EBITDA
-
EV/Sales
-2.26
Quick Ratio
9.40
Current Ratio
9.75
Debt/Eq
0.05
LT Debt/Eq
0.04
Option/Short
Yes / Yes
EPS (ttm)
-0.18
EPS next Y
-0.16
EPS next Q
-0.02
EPS this Y
33.33%
EPS next Y
-60.00%
EPS next 5Y
-
EPS past 3/5Y
56.76% 23.22%
Sales past 3/5Y
-4.49% -9.19%
EPS Y/Y TTM
47.75%
Sales Y/Y TTM
-34.46%
EPS Q/Q
53.75%
Sales Q/Q
-0.85%
Insider Own
4.08%
Insider Trans
0.00%
Inst Own
74.79%
Inst Trans
-3.28%
ROA
-6.34%
ROE
-7.79%
ROIC
-12.00%
Gross Margin
50.82%
Oper. Margin
-55.98%
Profit Margin
-81.96%
SMA20
-2.74%
SMA50
-9.10%
SMA200
-31.67%
Trades
Shs Outstand
394.67M
Shs Float
378.61M
52W High
1.72 -64.19%
52W Low
0.59 4.74%
Volatility
4.11% 5.83%
ATR (14)
0.04
RSI (14)
40.30
Beta
1.50
Rel Volume
0.83
Avg Volume
1.22M
Volume
1,015,392
Perf Week
-0.16%
Perf Month
-14.68%
Perf Quarter
-23.01%
Perf Half Y
-36.40%
Perf YTD
-51.87%
Perf Year
-48.24%
Perf 3Y
-70.53%
Perf 5Y
-87.75%
Perf 10Y
-86.03%
Prev Close
0.61
Price
0.62
Change %
0.85%
Analysts 3 incl. previous ratings
Rating Distribution 1 Buy · 2 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Aug 13, 2025 Downgrade T TD Cowen
Buy → Hold $1.55 +151.6% Feb 27, 2025 Downgrade K KeyBanc Capital Markets
Overweight → Sector Weight Apr 16, 2024 Initiated T TD Cowen
Buy $3.50 +468.2% Apr 04, 2024 Initiated J Jefferies
Buy $3.25 +427.6% Jul 12, 2023 Initiated K KeyBanc Capital Markets
Overweight $4 +549.4%
Nov-03-26 07:30AM
Oct-05-26 04:05PM
Sep-30-26 04:42PM
Sep-11-26 01:05PM
Aug-05-26 04:25PM
04:05PM
Loading…
04:05PM
Jul-28-26 08:00AM
Jul-22-26 07:00AM
Jul-21-26 02:53PM
Jul-20-26 07:30AM
Jun-15-26 01:29PM
Jun-09-26 07:50AM
Jun-08-26 07:30AM
May-05-26 05:38PM
04:05PM
07:00AM
Loading…
Apr-21-26 07:00AM
Feb-24-26 04:34PM
(Associated Press Finance)
04:10PM
Feb-10-26 07:00AM
Jan-30-26 09:09AM
Jan-08-26 07:00AM
Nov-19-25 11:30AM
Nov-10-25 12:15PM
Nov-04-25 05:31PM
(Associated Press Finance)
04:05PM
Nov-03-25 08:01AM
Oct-21-25 07:00AM
Sep-03-25 09:15AM
Aug-11-25 07:00PM
06:09PM
(Associated Press Finance)
04:01PM
Loading…
04:01PM
Aug-08-25 09:25AM
Aug-07-25 05:30PM
Aug-06-25 07:00AM
Jul-21-25 07:00AM
Jun-26-25 08:07AM
Jun-25-25 12:16AM
Jun-23-25 07:13AM
07:05AM
06:58AM
May-30-25 07:00AM
May-09-25 05:00PM
May-07-25 08:26AM
(Thomson Reuters StreetEvents)
03:20AM
May-06-25 05:15PM
04:01PM
May-05-25 10:10AM
Apr-24-25 07:00AM
Apr-22-25 04:05PM
07:00AM
Feb-27-25 04:01PM
07:09AM
(Thomson Reuters StreetEvents)
02:22AM
Feb-26-25 06:52PM
(Associated Press Finance)
-7.14%
04:01PM
Feb-25-25 10:54AM
Feb-12-25 07:00AM
Jan-13-25 07:00AM
Jan-08-25 07:00AM
Dec-19-24 08:00AM
Nov-07-24 08:00AM
Oct-31-24 11:00AM
08:01AM
Oct-30-24 05:20PM
04:15PM
(Associated Press Finance)
04:01PM
Oct-21-24 09:03PM
Oct-16-24 08:00AM
Oct-03-24 04:56AM
Sep-24-24 08:00AM
Sep-18-24 08:00AM
Aug-26-24 08:00AM
Aug-23-24 06:03PM
Aug-06-24 04:01PM
Aug-01-24 09:14AM
(Thomson Reuters StreetEvents)
-36.61%
Jul-31-24 09:57PM
05:40PM
04:36PM
(Associated Press Finance)
04:02PM
04:01PM
Jul-17-24 08:01AM
May-28-24 04:01PM
May-22-24 04:01PM
May-20-24 08:00AM
May-13-24 10:45AM
May-08-24 08:59PM
(InvestorPlace)
-5.49%
+7.59%
04:33PM
(Associated Press Finance)
04:01PM
Apr-25-24 11:27AM
08:01AM
08:00AM
Apr-08-24 08:00AM
Apr-03-24 04:01PM
Mar-18-24 08:12AM
Mar-05-24 08:27AM
Feb-29-24 06:29AM
(Thomson Reuters StreetEvents)
-5.06%
Feb-28-24 04:41PM
04:16PM
(Associated Press Finance)
04:01PM
Feb-26-24 08:00AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Egholm Michael President & CEO Apr 06 '26 Option Exercise 0.00 196,513 0 6,790,596 Apr 08 09:55 PM Kim Hanjoon Alex Chief Financial Officer Apr 06 '26 Option Exercise 0.00 70,183 0 2,800,702 Apr 08 09:55 PM Casdin Partners Master Fund, L Director Dec 04 '25 Buy 1.45 150,000 217,020 72,100,000 Dec 04 08:59 PM Casdin Partners Master Fund, L Director Dec 02 '25 Buy 1.42 125,000 177,512 71,875,000 Dec 04 08:59 PM Casdin Partners Master Fund, L Director Dec 03 '25 Buy 1.44 75,000 108,037 71,950,000 Dec 04 08:59 PM Casdin Partners Master Fund, L Director Nov 25 '25 Buy 1.30 7,550,000 9,838,405 71,750,000 Nov 26 04:58 PM Casdin Partners Master Fund, L Director Nov 24 '25 Buy 1.43 150,000 214,875 64,200,000 Nov 26 04:58 PM Casdin Partners Master Fund, L Director Nov 20 '25 Buy 1.30 450,000 586,260 64,050,000 Nov 20 07:45 PM Casdin Partners Master Fund, L Director Nov 19 '25 Buy 1.28 350,000 448,910 63,600,000 Nov 20 07:45 PM Casdin Partners Master Fund, L Director Nov 18 '25 Buy 1.23 275,000 339,405 63,250,000 Nov 20 07:45 PM Casdin Partners Master Fund, L Director Nov 13 '25 Buy 1.20 450,000 541,395 62,500,000 Nov 17 06:58 PM Casdin Partners Master Fund, L Director Nov 14 '25 Buy 1.24 250,000 309,800 62,750,000 Nov 17 06:58 PM Casdin Partners Master Fund, L Director Nov 17 '25 Buy 1.22 225,000 275,580 62,975,000 Nov 17 06:58 PM Casdin Partners Master Fund, L Director Nov 12 '25 Buy 1.19 375,000 445,838 62,050,000 Nov 12 07:46 PM Casdin Partners Master Fund, L Director Nov 11 '25 Buy 1.20 300,000 358,800 61,675,000 Nov 12 07:46 PM Casdin Partners Master Fund, L Director Nov 10 '25 Buy 1.17 275,000 321,915 61,375,000 Nov 12 07:46 PM Casdin Partners Master Fund, L Director Nov 07 '25 Buy 1.12 225,000 252,765 61,100,000 Nov 12 07:46 PM
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in Boston, MA.
President Dr. Michael Egholm Ph.D.
Chief Financial Officer Mr. Hanjoon Kim
Senior VP & Chief Business Officer Mr. Sean Mackay
VP & Chief Accounting Officer Mr. Jonathan Mickelsen
Vice President of Investor Relations John Graziano